It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Energy metabolism and reproduction are closely linked; however, the role of the individual energy metabolism hormones in this association is still poorly understood. Irisin is a hormone produced mostly by skeletal muscle cells during exercise or shivering, and leptin is a satiety adipokine synthesized by the white adipose tissue. The aim of this study was to investigate the in vitro effects of irisin and leptin on steroidogenesis in cultured human granulosa cells. The cells were purified from follicular fluid samples from patients undergoing in vitro fertilization (IVF). Primary cell cultures were treated with increasing concentrations of irisin (0, 125, 250, 500, 1,000, and 2,000 ng/ml) or leptin (0, 25, 50, 100, 200, and 400 ng/ml) for 24 hours and subjected to qRT-PCR analysis for the expression of key steroidogenic enzymes (CYP11A1, CYP19A1, CYP21A1, HSD3B1, and HSD17B3). Concentrations of progesterone, testosterone and estradiol in the conditioned cell culture medium were measured using ELISA. Results demonstrated that both irisin and leptin significantly upregulated CYP19A1 mRNA expression. Leptin also increased the expression of HSD3B1 mRNA levels. Although not statistically significant, leptin produced a trend of increasing estradiol production after 24 hours of treatment. Taken together, these data support the hypothesis that irisin and leptin may affect steroid hormone metabolism in the ovary by modulating the expression of key steroidogenic enzymes.
Presentation: Monday, June 13, 2022 12:30 p.m. - 2:30 p.m.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer